Fármacos de uso frecuente en dermatología como terapia para COVID-19

Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega-Peña, M., González-Cuevas, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AEDV. Published by Elsevier España, S.L.U. 2021
Materias:
Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546972/
https://www.ncbi.nlm.nih.gov/pubmed/33045209
http://dx.doi.org/10.1016/j.ad.2020.09.004
Descripción
Sumario:Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.

Ejemplares similares